Company: HQL
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001104659-25-034659
Chunk: 0

Company: abrdn Life Sciences Investors
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 0
---
<div align='center'>UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒ Definitive
Proxy Statement

☐ Definitive Additional Materials

☐ Soliciting Material under §240.14a-12

<div align='center'>abrdn Healthcare Investors

abrdn Life Sciences Investors

abrdn Healthcare Opportunities Fund

abrdn World Healthcare Fund

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other
than the Registrant)</div>

Payment of Filing Fee (Check the appropriate box):

☒ No
fee required.

☐
Fee paid previously with preliminary materials.

☐
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(l) and 0-11.

ABRDN HEALTHCARE INVESTORS
ABRDN LIFE SCIENCES INVESTORS
ABRDN HEALTHCARE OPPORTUNITIES FUND
ABRDN WORLD HEALTHCARE FUND
1900 Market Street, Suite 200
Philadelphia, PA 19103 NOTICE OF ANNUAL MEETINGS OF SHAREHOLDERS
To be held on May 28, 2025 TO THE SHAREHOLDERS: NOTICE IS HEREBY GIVEN that the annual meeting of shareholders of each of abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund and abrdn World Healthcare Fund (each, a "Fund," and collectively, the "Funds") and any adjournments or postponements thereof will be held at the offices of abrdn Inc., located at 1900 Market Street, Suite 200, Philadelphia, PA 19103 (each meeting, an "Annual Meeting," and collectively, the "Annual Meetings") on the following dates and at the following times:

| abrdn Healthcare Investors (NYSE: HQH)          
 abrdn Life Sciences